Art

J-GLOBAL ID：200902295115063016   Reference number：06A0470195

Difference in R&D Process of New Drugs among Bio Startups of Different Business Models: Comparison of Business Strategy among six Bio Startups

創薬プロセスのビジネス・モデルによる差異-創薬ベンチャー6社の戦略比較-

Author (1)： OZAKI HIROYUKI (東京工科大)
Material： 経営情報学会誌  (Journal of the Japan Society for Management Information)
Volume： 15  Issue： 1  Page： 63-78  Publication year： Jun. 2006 
JST Material Number： L4480A  ISSN： 0918-7324  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *venture business ,...
Semi thesaurus term： *ビジネスモデル

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0470195&from=J-GLOBAL&jstjournalNo=L4480A") }}

JST classification (1)： Management engineering in general  (KA01010C)

Reference (21)：

• Balachandra R.(2000) “An expert system for new product development projects”, Industrial Management & Data System, 100/7, pp317-324.
• Cooper G. Robert (2001),“Winning at New Products-Accelerating the process from idea to launch”, Perseus Publishing, Cambridge, MA.
• Cumby Judy and Conrod Joan (2001) “Non-financial performance measures in the Canadian biotechnology industry”, Journal of Intellectual Capital, Vol, 2 No.3, pp. 261-272.
• Deeds D. Hill C.(1996),“Strategic Alliances and the Rate of New Product Development: An Empirical Study of Entrepreneurial Biotechnology Firms”. Journal of Business Venturing, Vol.11, pp41-55.
• Deeds L. David, DeCarolis Dona, and Coombs Joseph (1997) “The impact of firm-specific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry”, Journal of Business Venturing, Vol.12, pp31-46.

Terms in the title (6)： 創薬 ,  プロセス ,  ビジネス ,  モデル ,  差異 ,  戦略